EBIT: Income before interest and taxes.
Alterity Therapeutics Limited - Sponsored ADR (ATHE) had EBIT of $-12.98M for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-7.87M |
|
-- |
|
-- |
|
$12.98M |
|
$-12.98M |
|
$5.16M |
|
$-7.82M |
|
$-7.82M |
|
$-7.87M |
|
$-7.87M |
|
$-7.87M |
|
$-7.87M |
|
|
EBIT |
$-12.98M |
$-12.89M |
|
10.66M |
|
10.66M |
|
$-0.74 |
|
$-0.74 |
|
| Balance Sheet Financials | |
$29.71M |
|
$0.00M |
|
$0.10M |
|
$29.81M |
|
$2.29M |
|
-- |
|
$0.06M |
|
$2.35M |
|
$27.46M |
|
$27.46M |
|
$27.46M |
|
15.21M |
|
| Cash Flow Statement Financials | |
$-7.42M |
|
$-4.86M |
|
$25.69M |
|
$8.18M |
|
$21.47M |
|
$13.29M |
|
$0.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.65% |
|
-28.65% |
|
-26.39% |
|
-28.65% |
|
$1.81 |
|
$-0.70 |
|
$-0.70 |
|